Preclinical modeling has demonstrated its importance in recruiting CD8+ T cells to the tumor microenvironment via CCL5, CXCL9, and CDCL10 chemokine release (Carretero et al., 2015; Varricchi et al., 2017). Here, CCL5 is linked to neoplasm.